A two part study to a) investigate the reproducilibility of the vaginal photoplethysmography (VPP) technique in healthy pre-menopausal volunteers and subjects suffering from Female Sexual Arousal Disorder (FSAD) and b) a randomised double blind, placebo conrolled 4-way crossover study to investigate the effect of single oral doses (10, 50 and 400 mg)of UK-447,841 on vaginal blood flow in pre-menopausal subjects suffering from FSAD.

Trial Profile

A two part study to a) investigate the reproducilibility of the vaginal photoplethysmography (VPP) technique in healthy pre-menopausal volunteers and subjects suffering from Female Sexual Arousal Disorder (FSAD) and b) a randomised double blind, placebo conrolled 4-way crossover study to investigate the effect of single oral doses (10, 50 and 400 mg)of UK-447,841 on vaginal blood flow in pre-menopausal subjects suffering from FSAD.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Aug 2011

At a glance

  • Drugs UK 447841 (Primary)
  • Indications Female sexual dysfunction
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 15 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top